CHAD flirts with distributors, sleep
CHATSWORTH, Calif. -- CHAD Therapeutics said last month that the company was talking to several distributors about formalizing distribution agreements for its Total O2 oxygen transfilling system. Total 02 sales jumped 62% in FY 2005 over the previous year. CHAD also reported in its year-end earnings news that its fledgling, new sleep device -- the particulars of which have yet to be disclosed -- reduced the amount of air pressure needed to treat sleep apnea patients. The new device uses proprietory sensor technology. CHAD expects to make decisions about how to distribute the new sleep product this summer.